Nationally Notifiable Infectious Diseases and Conditions, United States: Annual Tables

TABLE 2p. Annual reported cases of notifiable diseases, by region and reporting area, United States and U.S. Territories, excluding Non-U.S. Residents*, 2019
Data from some jurisdictions may be incomplete due to the coronavirus disease 2019 (COVID-19) pandemic. Please see Note #9 at the bottom of the table.
Reporting Area Spotted fever rickettsiosis Streptococcal toxic shock syndrome Syphilis
Total Confirmed Probable Total, all stages § Congenital Primary and secondary
U.S. Residents, excluding U.S. Territories 5,207 128 5,079 416 129,813 1,870 38,992
New England 40 40 66 3,044 14 1,034
Connecticut 5 5 31 482 3 210
Maine 5 5 20 136 55
Massachusetts 15 15 6 1,844 9 610
New Hampshire 8 8 135 2 47
Rhode Island 2 423 101
Vermont 7 7 7 24 11
Middle Atlantic 313 23 290 14 15,349 55 4,487
New Jersey 209 2 207 8 2,085 15 631
New York (excluding New York City) 71 14 57 5 2,164 10 886
New York City 4 2 2 8,336 17 1,979
Pennsylvania 29 5 24 1 2,764 13 991
East North Central 285 7 278 138 9,983 83 3,316
Illinois 136 4 132 92 4,511 32 1,374
Indiana 76 1 75 27 993 13 336
Michigan 10 10 5 1,905 17 678
Ohio 49 2 47 14 2,005 19 749
Wisconsin 14 14 569 2 179
West North Central 744 11 733 31 4,713 51 1,753
Iowa 11 11 N 359 1 132
Kansas 213 2 211 3 565 9 190
Minnesota 7 7 13 1,127 21 385
Missouri 483 5 478 15 2,188 18 817
Nebraska 16 1 15 291 136
North Dakota 4 4 97 45
South Dakota 10 3 7 86 2 48
South Atlantic 1,317 35 1,282 93 28,902 292 8,585
Delaware 36 1 35 216 2 94
District of Columbia 7 3 4 1,085 1 308
Florida 27 1 26 N 12,121 145 3,189
Georgia 27 4 23 53 5,679 52 1,750
Maryland 137 137 2,778 31 868
North Carolina 679 15 664 13 3,369 27 1,122
South Carolina 77 11 66 2 1,306 17 516
Virginia 302 302 21 2,071 11 659
West Virginia 25 25 4 277 6 79
East South Central 1,269 25 1,244 14 6,962 40 2,422
Alabama 476 6 470 N 1,634 15 618
Kentucky 347 8 339 14 1,096 9 438
Mississippi 114 3 111 N 2,006 3 690
Tennessee 332 8 324 2,226 13 676
West South Central 1,126 7 1,119 18,257 660 4,252
Arkansas 1,081 5 1,076 1,106 21 404
Louisiana 22 22 2,744 68 700
Oklahoma N 1,750 43 791
Texas 23 2 21 N 12,657 528 2,357
Mountain 90 16 74 59 9,868 194 3,358
Arizona 49 10 39 4,022 109 1,290
Colorado 3 3 1 1,434 10 486
Idaho 13 4 9 3 149 1 47
Montana 2 2 2 140 1 67
Nevada 7 7 30 2,356 41 808
New Mexico 1,294 28 511
Utah 10 2 8 23 431 4 138
Wyoming 6 6 42 11
Pacific 23 4 19 1 32,735 481 9,785
Alaska N N N N 242 129
California 15 1 14 N 28,812 445 8,266
Hawaii N N N 1 252 3 120
Oregon 4 1 3 N 1,245 18 454
Washington 4 2 2 N 2,184 15 816
U.S. Territories 1,027 7 335
American Samoa N N N N
Commonwealth of Northern Mariana Islands 2 1
Guam N N N 31 5
Puerto Rico N N N N 949 7 329
U.S. Virgin Islands 45
  • —: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • U: Unavailable — The data are unavailable.
  • * The 2019 annual tables exclude cases of nationally notifiable conditions and diseases among non-U.S. residents. As a result, data in Table 2 does not include a "Non-U.S. Resident" or "Total" row, that would have been included in the table had the data been stratified into the following four categories, based upon the "country of usual residence" (COUR) algorithm: U.S. Residents, excluding U.S. Territories; U.S. Territories; Non-US. Residents; and Total.Table 2 for the 2019 annual tables only includes the first two of these stratification categories.
  • † To calculate rates, use the populations provided in Table 8. Note that calculation of rates for the following conditions use population subsets presented in Table 8: Zika virus infection, congenital; Zika virus disease, congenital; Infant botulism; Congenital rubella syndrome; Perinatal Hepatitis B infection, Perinatal Hepatitis C infection, Haemophilus influenzae, invasive disease and Invasive pneumococcal disease, and Influenza associated pediatric mortality; see Table 8 (population reference table). Also see notes 3 and 7.
  • § Includes the following categories: primary; secondary; early non-primary non-secondary (includes cases previously reported as early latent); and unknown duration or late (includes cases previously reported as late latent syphilis and cases previously reported as late syphilis with clinical manifestations).